Li Z[au] - Search Results

Year	Number of Results
1958	1
1964	1
1979	8
1980	20
1981	25
1982	27
1983	49
1984	43
1985	58
1986	60
1987	71
1988	75
1989	82
1990	93
1991	104
1992	99
1993	153
1994	152
1995	168
1996	236
1997	234
1998	256
1999	267
2000	323
2001	364
2002	489
2003	601
2004	765
2005	984
2006	1116
2007	1230
2008	1597
2009	1915
2010	2159
2011	2570
2012	3040
2013	3612
2014	4247
2015	4986
2016	5211
2017	5834
2018	6928
2019	8324
2020	9853
2021	11495
2022	7079
2023	4

1

Retraction Note: Wogonin reversed resistant human myelogenous leukemia cells via inhibiting Nrf2 signaling by Stat3/NF-κB inactivation.

Xu X, Zhang X, Zhang Y, Yang L, Liu Y, Huang S, Lu L, Kong L, Li Z, Guo Q, Zhao L. Xu X, et al. Among authors: li z. Sci Rep. 2022 May 30;12(1):9007. doi: 10.1038/s41598-022-13462-0. Sci Rep. 2022. PMID: 35637378 Free PMC article. No abstract available.

2

Retraction Notice to: Overexpressed lncRNA GATA6-AS1 Inhibits LNM and EMT via FZD4 through the Wnt/β-Catenin Signaling Pathway in GC.

Li ZT, Zhang X, Wang DW, Xu J, Kou KJ, Wang ZW, Yong G, Liang DS, Sun XY. Li ZT, et al. Mol Ther Nucleic Acids. 2022 May 10;28:594. doi: 10.1016/j.omtn.2022.05.013. eCollection 2022 Jun 14. Mol Ther Nucleic Acids. 2022. PMID: 35615007 Free PMC article.

3

Retraction notice to "LncRNA SNHG6 facilitates cell proliferation, migration, invasion and EMT by upregulating UCK2 and activating the Wnt/ß-catenin signaling in cervical cancer" [Bioorg. Chem. 120 (2022) 105488].

Wei J, Gao Y, Li Z, Jia H, Han B. Wei J, et al. Among authors: li z. Bioorg Chem. 2022 Mar;120:105886. doi: 10.1016/j.bioorg.2022.105886. Epub 2022 May 26. Bioorg Chem. 2022. PMID: 35644081 No abstract available.

4

[Retracted] MicroRNA‑766 inhibits papillary thyroid cancer progression by directly targeting insulin receptor substrate 2 and regulating the PI3K/Akt pathway.

Zhao J, Li Z, Chen Y, Zhang S, Guo L, Gao B, Jiang Y, Tian W, Hao S, Zhang X. Zhao J, et al. Among authors: li z. Int J Oncol. 2022 Jul;61(1):86. doi: 10.3892/ijo.2022.5376. Epub 2022 Jun 1. Int J Oncol. 2022. PMID: 35642668 Free PMC article.

5

CO₂-elevated cell-free protein synthesis.

Lin X, Zhou C, Wang T, Huang X, Chen J, Li Z, Zhang J, Lu Y. Lin X, et al. Among authors: li z. Synth Syst Biotechnol. 2022 May 20;7(3):911-917. doi: 10.1016/j.synbio.2022.05.002. eCollection 2022 Sep. Synth Syst Biotechnol. 2022. PMID: 35664930 Free PMC article.

6

Single-molecule nano-optoelectronics: Insights from physics.

Li P, Li Z, Zhao C, Ju H, Gao Q, Si W, Cheng L, Hao J, Li M, YiChen Y, Jia C, Guo X. Li P, et al. Among authors: li z. Rep Prog Phys. 2022 May 27. doi: 10.1088/1361-6633/ac7401. Online ahead of print. Rep Prog Phys. 2022. PMID: 35623319

7

PKCβII-ACSL4 pathway mediating ferroptosis execution and anti-tumor immunity.

Lei G, Horbath A, Li Z, Gan B. Lei G, et al. Among authors: li z. Cancer Commun (Lond). 2022 Jun 8. doi: 10.1002/cac2.12319. Online ahead of print. Cancer Commun (Lond). 2022. PMID: 35674490 No abstract available.

8

Nanoscale thermoplasmonic welding.

Wang L, Feng Y, Li Z, Liu G. Wang L, et al. Among authors: li z. iScience. 2022 May 18;25(6):104422. doi: 10.1016/j.isci.2022.104422. eCollection 2022 Jun 17. iScience. 2022. PMID: 35663015 Free PMC article. Review.

9

Genomic landscape of T-cell lymphoblastic lymphoma.

Li Z, Song Y, Zhang M, Wei Y, Ruan H. Li Z, et al. Chin J Cancer Res. 2022 Apr 30;34(2):83-94. doi: 10.21147/j.issn.1000-9604.2022.02.03. Chin J Cancer Res. 2022. PMID: 35685993 Free PMC article.

10

Cellular and molecular mechanisms of plasticity in cancer.

Torborg SR, Li Z, Chan JE, Tammela T. Torborg SR, et al. Among authors: li z. Trends Cancer. 2022 May 23:S2405-8033(22)00094-2. doi: 10.1016/j.trecan.2022.04.007. Online ahead of print. Trends Cancer. 2022. PMID: 35618573 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results